F/M Investments’s Soleno Therapeutics SLNO Stock Holding History

F/M Investments’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,351	Closed	-$983K	–	378
2026 Q1	$983K	Sell	29,351 -520	-2%	-$20.4K	0.07%	168
2025 Q4	$1.38M	Sell	29,871 -25,859	-46%	-$1.42M	0.05%	272
2025 Q3	$3.77M	Buy	55,730 +16,189	+41%	+$1.2M	0.15%	167
2025 Q2	$3.31M	Sell	39,541 -11,226	-22%	-$840K	0.12%	185
2025 Q1	$3.63M	Buy	50,767 +2,973	+6%	+$145K	0.14%	154
2024 Q4	$2.15M	Buy	+47,794	New	+$2.48M	0.08%	221

F/M Investments's SLNO Position: Q2 2026 in Review

F/M Investments sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 29,351 shares — an estimated $983K sold.

F/M Investments first reported a position in SLNO in Q4 2024 and held it in 6 quarters. The position peaked at $3.77M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

F/M Investments reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
F/M Investments sold 29,351 Soleno Therapeutics shares in Q2 2026, an estimated $983K.
F/M Investments first reported a position in Soleno Therapeutics in Q4 2024 and held it in 6 quarters.
F/M Investments's Soleno Therapeutics position peaked at $3.77M in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.